secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2024-10-25T23:59:59+00:00
Accession:  0000950170-24-117439
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo shareholders approve reverse stock split (1:5–1:37) and dilutive stock issuance
--------------------------------------------------------------------------------

- Stock issuance and warrant proposal passed (593,301 For, 412,901 Against, 5,355 Abstain).
- Reverse stock split approved at ratio of 1-for-5 to 1-for-37; board sets timing and exact ratio.
- Adjournment proposal also approved (2,017,270 For, 1,253,171 Against, 9,145 Abstain).
- Issuance covers >19.99% of outstanding common stock with price adjustment warrants per Sept 16 agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024117439/0000950170-24-117439-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024117439/apvo-20241025.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-117439

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer